TrialClinical pharmacokinetics2015

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection.

Florence Namour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.